Jump to ContentJump to Main Navigation
Show Summary Details
In This Section

Biological Chemistry

Editor-in-Chief: Brüne, Bernhard

Editorial Board Member: Buchner, Johannes / Lei, Ming / Ludwig, Stephan / Sies, Helmut / Thomas, Douglas D. / Turk, Boris / Wittinghofer, Alfred

12 Issues per year

IMPACT FACTOR 2016: 3.273

CiteScore 2016: 3.01

SCImago Journal Rank (SJR) 2015: 1.607
Source Normalized Impact per Paper (SNIP) 2015: 0.751

See all formats and pricing
In This Section
Volume 380, Issue 6 (Jun 1999)


Human Fc gamma Receptor IIb Expressed in <I>Escherichia coli</I> Reveals IgG Binding Capability

P. Sondermann / U. Jacob
Published Online: 2005-06-01 | DOI: https://doi.org/10.1515/BC.1999.090


Fcγ receptors (FcγR) are expressed on immunologically active cells where they trigger B and T cell responses and are responsible for the clearance of immunocomplexes. They occur as type I transmembrane proteins and also in soluble forms (sFcR) comprising only the ecto domains of the receptors. State-of-the-art research has generated demand for highly pure and homogeneous sFcγR preparations: first, studies of the immunoregulative potential of the soluble FcγRs have been hampered by co-purified growth factors. Second, they are needed for crystallographic analyses to solve questions such as the exact location of the binding site for IgG on the receptor, and the graded affinities of the receptors for different IgG subclasses. This has been unsuccessful due to limitations in availability and homogeneity of sFcγR expressed in eukaryotic cells. In order to address these problems we expressed the extracellular part of the human Fc-γRIIb in E. coli. The protein was refolded, purified in a three-step procedure and characterized by SDS-PAGE, mass spectrometry as well as N-terminal sequencing. The unglycosylated FcγRIIb is active because it binds immobilized antibody as well as the IgG Fc-fragment in solution. Finally, the receptor was crystallized in orthorhombic, tetragonal and hexagonal crystal forms that diffracted X-rays to resolutions of 1.7 Å, 2.7 Å and 3.8 Å respectively.

About the article

Published Online: 2005-06-01

Published in Print: 1999-06-01

Citation Information: Biological Chemistry, ISSN (Online) 1437-4315, ISSN (Print) 1431-6730, DOI: https://doi.org/10.1515/BC.1999.090. Export Citation

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

Sang Taek Jung
Biotechnology and Bioprocess Engineering, 2013, Volume 18, Number 4, Page 625
Ralf J. Ludwig, Kathrin Kalies, Jörg Köhl, Detlef Zillikens, and Enno Schmidt
Trends in Molecular Medicine, 2013, Volume 19, Number 8, Page 501
Peter Sondermann, Jens Kaiser, and Uwe Jacob
Journal of Molecular Biology, 2001, Volume 309, Number 3, Page 737
Ryutaro Asano, Makoto Nakayama, Hiroko Kawaguchi, Tsuguo Kubota, Takeshi Nakanishi, Mitsuo Umetsu, Hiroki Hayashi, Yu Katayose, Michiaki Unno, Toshio Kudo, and Izumi Kumagai
FEBS Journal, 2012, Volume 279, Number 2, Page 223
Xiaohui Tian, Aiping Wang, Songlin Qiao, Gaiping Zhang, Jun Xi, Xuewu Li, Yunchao Liu, and Yuqing Xu
Protein Expression and Purification, 2009, Volume 68, Number 1, Page 12
Jin-Li Zhang, Manfred Buehner, and Walter Sebald
European Journal of Biochemistry, 2002, Volume 269, Number 5, Page 1490
Peter Sondermann and Vaughan Oosthuizen
Immunology Letters, 2002, Volume 82, Number 1-2, Page 51
Sofia E. Magnusson, Maria Andrén, Kajsa E. Nilsson, Peter Sondermann, Uwe Jacob, and Sandra Kleinau
Clinical Immunology, 2008, Volume 127, Number 2, Page 225
Sang Taek Jung, Tae Hyun Kang, and George Georgiou
Biotechnology and Bioengineering, 2010, Volume 107, Number 1, Page 21
Jinghua Lu, Lorraine L. Marnell, Kristopher D. Marjon, Carolyn Mold, Terry W. Du Clos, and Peter D. Sun
Nature, 2008, Volume 456, Number 7224, Page 989

Comments (0)

Please log in or register to comment.
Log in